The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease

被引：6
作者：
Pineles, David [1 ]
Malter, Lisa [2 ]
Liang, Peter S. [3 ]
Arsuaga, Amy [4 ]
Bosworth, Brian [1 ,4 ]
Hudesman, David P. [4 ]
Chang, Shannon [4 ]
机构：
[1] NYU Langone Hlth, Dept Med, New York, NY USA
[2] Bellevue Hosp, Div Gastroenterol, New York, NY USA
[3] Manhattan Med Ctr, VA New York Harbor Healthcare Syst, Div Gastroenterol, New York, NY USA
[4] NYU Langone Hlth, Div Gastroenterol, Inflammatory Bowel Dis Ctr, New York, NY 10016 USA
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 74卷 / 10期
关键词：
D O I：
10.1007/s00228-018-2492-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1361 / 1362
页数：2
相关论文
共 50 条
  • [21] PATIENT AND PROFESSIONALS PERCEPTIONS OF TRAVEL BEHAVIOUR IN INFLAMMATORY BOWEL DISEASE
    Mulligan, J-P
    Greveson, K.
    Shepherd, T.
    Hamilton, M.
    Murray, C. D.
    GUT, 2014, 63 : A79 - A80
  • [22] PATIENT PERCEPTIONS OF ENDOSCOPIC TESTING IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE
    Duncan, Eric
    Sanon, Myrlene
    Griffo, Cindy
    Amatelli, Doreen
    Barthelmes, Jennifer
    Wirth, Daniel
    Kachroo, Sumesh
    Lee, Rebecca
    Hoops, Timothy
    Naessens, Dominik
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S85 - S85
  • [23] Canadian Patient and Caregiver Perspectives on Subsequent Entry Biologics/Biosimilars for Inflammatory Bowel Disease
    Attara, Gail
    Bressler, Brian
    Bailey, Robert
    Marshall, John. K.
    Panaccione, Remo
    Aumais, Guy
    GASTROENTEROLOGY, 2016, 150 (04) : S443 - S444
  • [24] PATIENT PERCEPTIONS OF ENDOSCOPIC TESTING IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE
    Duncan, Eric
    Sanon, Myrlene
    Griffo, Cindy
    Amatelli, Doreen
    Barthelmes, Jennifer
    Wirth, Daniel
    Kachroo, Sumesh
    Lee, Rebecca
    Hoops, Timothy
    Naessens, Dominik
    GASTROENTEROLOGY, 2024, 166 (03) : S117 - S117
  • [25] Canadian patient and caregiver perspectives on subsequent entry biologics/biosimilars for inflammatory bowel disease
    Attara, G.
    Bailey, R.
    Bressler, B.
    Marshall, J.
    Panaccione, R.
    Aumais, G.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S319 - S319
  • [26] Effect of race and ethnicity on perceptions of inflammatory bowel disease
    Finlay, DG
    Basu, D
    Sellin, JH
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (06) : 503 - 507
  • [27] Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease
    Raffals, Laura E.
    Nguyen, Geoffrey C.
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 818 - 823
  • [28] Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence
    McConachie, Sean
    Wilhelm, Sheila M.
    Kale-Pradhan, Pramodini B.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (04) : 391 - 400
  • [29] The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease
    Patil, Seema A.
    Bhat, Shubha
    Limdi, Jimmy K.
    Farraye, Francis A.
    Cross, Raymond K.
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (12) : 1915 - 1923
  • [30] Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?
    Argollo, Marjorie
    Fiorino, Gionata
    Gilardi, Daniela
    Furfaro, Federica
    Roda, Giulia
    Loy, Laura
    Allocca, Mariangela
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (01) : 7 - 12
12345